Zevra Therapeutics (ZVRA) Debt Ratio (2014 - 2025)

Zevra Therapeutics (ZVRA) has 8 years of Debt Ratio data on file, last reported at 0.22 in Q4 2025.

• Quarterly Debt Ratio fell 34.89% year-over-year to 0.22 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.22 (down 34.89% YoY) and the FY2025 annual result came in at 0.22, down 34.89% from the prior year.
• Debt Ratio slipped to 0.22 in Q4 2025, from 0.23 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.4 in Q2 2024 to a low of 0.01 in Q1 2021.
• A 5-year average of 0.25 and a median of 0.25 in 2023 frame the typical range for Debt Ratio.
• The widest YoY moves for Debt Ratio: up 38.74% in 2025, down 41.37% in 2025.
• Tracing ZVRA's Debt Ratio over 5 years: stood at 0.01 in 2021, then surged by 1092.81% to 0.1 in 2022, then soared by 140.91% to 0.25 in 2023, then surged by 34.61% to 0.33 in 2024, then tumbled by 34.89% to 0.22 in 2025.
• The last three Debt Ratio figures came in at 0.22 (Q4 2025), 0.23 (Q3 2025), and 0.24 (Q2 2025), per Business Quant data.